Lys-Thr-Trp-Tyr
Internal ID | 6f104808-431e-4fb7-bb36-7d6d069341b8 |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
IUPAC Name | (2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid |
SMILES (Canonical) | CC(C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CCCCN)N)O |
SMILES (Isomeric) | C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O |
InChI | InChI=1S/C30H40N6O7/c1-17(37)26(36-27(39)22(32)7-4-5-13-31)29(41)34-24(15-19-16-33-23-8-3-2-6-21(19)23)28(40)35-25(30(42)43)14-18-9-11-20(38)12-10-18/h2-3,6,8-12,16-17,22,24-26,33,37-38H,4-5,7,13-15,31-32H2,1H3,(H,34,41)(H,35,40)(H,36,39)(H,42,43)/t17-,22+,24+,25+,26+/m1/s1 |
InChI Key | JMENHIOOENGKIL-JGFWFPDNSA-N |
Popularity | 0 references in papers |
Molecular Formula | C30H40N6O7 |
Molecular Weight | 596.70 g/mol |
Exact Mass | 596.29584764 g/mol |
Topological Polar Surface Area (TPSA) | 233.00 Ų |
XlogP | -2.50 |
Atomic LogP (AlogP) | 0.03 |
H-Bond Acceptor | 8 |
H-Bond Donor | 9 |
Rotatable Bonds | 16 |
KTWY |
K-T-W-Y |
L-Lys-L-Thr-L-Trp-L-Tyr |
CHEBI:73597 |
L-lysyl-L-threonyl-L-tryptophyl-L-tyrosine |
Q27141909 |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9085 | 90.85% |
Caco-2 | - | 0.9089 | 90.89% |
Blood Brain Barrier | - | 0.7000 | 70.00% |
Human oral bioavailability | - | 0.5429 | 54.29% |
Subcellular localzation | Mitochondria | 0.5160 | 51.60% |
OATP2B1 inhibitior | - | 0.5670 | 56.70% |
OATP1B1 inhibitior | + | 0.9088 | 90.88% |
OATP1B3 inhibitior | + | 0.9475 | 94.75% |
MATE1 inhibitior | - | 0.9609 | 96.09% |
OCT2 inhibitior | - | 0.8500 | 85.00% |
BSEP inhibitior | + | 0.8988 | 89.88% |
P-glycoprotein inhibitior | + | 0.6774 | 67.74% |
P-glycoprotein substrate | + | 0.7600 | 76.00% |
CYP3A4 substrate | + | 0.6687 | 66.87% |
CYP2C9 substrate | - | 0.7965 | 79.65% |
CYP2D6 substrate | - | 0.7686 | 76.86% |
CYP3A4 inhibition | - | 0.9529 | 95.29% |
CYP2C9 inhibition | - | 0.8139 | 81.39% |
CYP2C19 inhibition | - | 0.8486 | 84.86% |
CYP2D6 inhibition | - | 0.8319 | 83.19% |
CYP1A2 inhibition | - | 0.7890 | 78.90% |
CYP2C8 inhibition | + | 0.5540 | 55.40% |
CYP inhibitory promiscuity | - | 0.7105 | 71.05% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.9200 | 92.00% |
Carcinogenicity (trinary) | Non-required | 0.6437 | 64.37% |
Eye corrosion | - | 0.9927 | 99.27% |
Eye irritation | - | 0.9476 | 94.76% |
Skin irritation | - | 0.8160 | 81.60% |
Skin corrosion | - | 0.9452 | 94.52% |
Ames mutagenesis | - | 0.8070 | 80.70% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.3651 | 36.51% |
Micronuclear | + | 0.7800 | 78.00% |
Hepatotoxicity | - | 0.7532 | 75.32% |
skin sensitisation | - | 0.8952 | 89.52% |
Respiratory toxicity | + | 0.8667 | 86.67% |
Reproductive toxicity | + | 0.9373 | 93.73% |
Mitochondrial toxicity | + | 0.8750 | 87.50% |
Nephrotoxicity | - | 0.6593 | 65.93% |
Acute Oral Toxicity (c) | III | 0.6585 | 65.85% |
Estrogen receptor binding | + | 0.7804 | 78.04% |
Androgen receptor binding | + | 0.7491 | 74.91% |
Thyroid receptor binding | + | 0.5364 | 53.64% |
Glucocorticoid receptor binding | + | 0.6497 | 64.97% |
Aromatase binding | - | 0.5091 | 50.91% |
PPAR gamma | + | 0.7005 | 70.05% |
Honey bee toxicity | - | 0.8623 | 86.23% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | - | 0.7300 | 73.00% |
Fish aquatic toxicity | - | 0.5358 | 53.58% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2581 | P07339 | Cathepsin D | 99.67% | 98.95% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 99.36% | 90.20% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.14% | 91.11% |
CHEMBL3837 | P07711 | Cathepsin L | 98.31% | 96.61% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.39% | 96.09% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.23% | 97.23% |
CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 96.37% | 97.21% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.30% | 95.56% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.21% | 99.17% |
CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 94.43% | 92.29% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.02% | 100.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.75% | 94.45% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 93.71% | 91.71% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 93.14% | 95.50% |
CHEMBL2535 | P11166 | Glucose transporter | 92.25% | 98.75% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.78% | 93.10% |
CHEMBL1808 | P12821 | Angiotensin-converting enzyme | 91.15% | 93.39% |
CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 90.47% | 100.00% |
CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 90.34% | 96.95% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 90.22% | 88.56% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 89.47% | 83.82% |
CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 88.83% | 100.00% |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 88.80% | 94.62% |
CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 87.99% | 96.28% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 87.19% | 93.56% |
CHEMBL3492 | P49721 | Proteasome Macropain subunit | 87.05% | 90.24% |
CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 86.91% | 88.10% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 86.68% | 82.86% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 86.39% | 98.33% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 85.23% | 99.15% |
CHEMBL2431 | P31751 | Serine/threonine-protein kinase AKT2 | 82.69% | 98.33% |
CHEMBL3176 | O43603 | Galanin receptor 2 | 82.26% | 98.89% |
CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 82.23% | 95.56% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 82.09% | 100.00% |
CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 | 81.07% | 97.53% |
CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 80.66% | 91.81% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 80.35% | 90.08% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Pinus strobus |
Torreya nucifera |
PubChem | 71464642 |
LOTUS | LTS0265385 |
wikiData | Q104253554 |